| Financial Year |
March 31 2023 |
| Monetary Funds |
87,749,218.48 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
158,900,005.25 |
| Advances to Suppliers |
3,438,938.54 |
| Other Receivables |
2,864,272.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
317,159,609.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,310,001.35 |
| Total Current Assets |
769,152,585.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,396,792.53 |
| Investment Properties |
-- |
| Fixed Assetes |
555,714,331.33 |
| Under-construction Projects |
54,905,569.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,319,411.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
4,640,904.65 |
| Other Non-Current Assets |
18,921,480.62 |
| Sub-Total of Non-Current Assets |
727,936,258.21 |
| Total Assets |
1,497,088,843.51 |
| Short-Term Loans |
95,084,205.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
142,557,993.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,498,426.57 |
| Taxes Payable |
7,514,314.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,848,958.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
661,806.98 |
| Other Current Liabilities |
672,463.13 |
| Sub-Total of Current Liabilities |
324,277,769.00 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
107,802,133.87 |
| Total Liabilities |
432,079,902.87 |
| Paid-In Capital(Or Share Stock) |
151,171,285.00 |
| Capital Surplus |
524,391,826.03 |
| Surplus Reserve |
45,177,946.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
344,170,885.57 |
| Minority Stockholder's Interest |
96,998.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,064,911,942.64 |
| Owner's Equity（Stockholder's Equity） |
1,065,008,940.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,497,088,843.51 |
